Sunitinib efficacy in patients with disseminated renal cell carcinoma
Renal cell carcinoma belongs to a category of chemoresistant tumors. An overall life span of the patients with the disseminated form of disease amounts 10—12 months. Molecular biology development has brought to appearance of the novel kind of systemic treatment — «target» therapy. Use of the given g...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2020-02-01
|
Series: | Onkourologiâ |
Online Access: | https://oncourology.abvpress.ru/oncur/article/view/1033 |